Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04866069
Recruitment Status : Recruiting
First Posted : April 29, 2021
Last Update Posted : May 6, 2021
Sponsor:
Collaborators:
The Scientific and Technological Research Council of Turkey
VETAL Inc.
MonitorCRO
Information provided by (Responsible Party):
Osman ERGANIS, PhD, Prof, The Scientific and Technological Research Council of Turkey

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : April 2022